[1]赵阳.紫草素对荷肝癌大鼠免疫功能的影响[J].西部中医药,2018,31(09):26-29.
　ZHAO Yang.Effects of Shikonin on Immunologic Function of the Rats Suffering Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(09):26-29.
点击复制

紫草素对荷肝癌大鼠免疫功能的影响()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
31
期数:
2018年09期
页码:
26-29
栏目:
出版日期:
2018-09-15

文章信息/Info

Title:
Effects of Shikonin on Immunologic Function of the Rats Suffering Liver Cancer
文章编号:
1004-6852(2018)09-0026-04
作者:
赵阳
邯郸市中心医院免疫科，河北 邯郸 056001
Author(s):
ZHAO Yang
Department of Immunology, Handan Municipality Central Hospital, Handan 056001, China
关键词:
肝癌; 免疫功能; 脾淋巴细胞转化率; 紫草素
Keywords:
liver cancer;  immunologic function;  splenic lymphocyte transformation rate;  Shikonin
分类号:
R285.5
文献标志码:
A
摘要:
目的：探讨紫草素(Shikonin)对荷肝癌大鼠免疫功能的影响及其作用机制。方法：采用腋窝皮下注射肝癌Walker-256细胞的方法建立荷肝癌移植瘤大鼠模型，设紫草素［40、20、10 mg/(kg·d)］组和顺铂［2 mg/(kg·d)］组(n=20)，腹腔注射给药，疗程14天。观察大鼠瘤体生长状况并计算抑瘤率，苏木精-尹红(HE)染色观察瘤体组织形态结构；噻唑蓝(MTT)比色法测定脾淋巴细胞转化率；酶联免疫吸附法(ELISA)测定血清白细胞介素2(IL-2)和肿瘤坏死因子α(TNF-α)；流式细胞术(flow cytometry，FCM)检测血液T淋巴细胞亚群CD4+、CD8+百分率并计算CD4+/CD8+比值。结果：与模型组比较，紫草素组荷肝癌大鼠瘤体缩小且硬度降低，瘤体组织呈现细胞皱缩、组织片状坏死等病理性改变；紫草素各剂量组抑瘤率升高(P＜0.05)；紫草素［40、20 mg/(kg·d)］组脾淋巴细胞转化率升高(P＜0.05)，血清中IL-2、TNF-α含量降低(P＜0.05)，紫草素［40 mg/(kg·d)］组大鼠血液中CD4+百分率升高(P＜0.05)、紫草素［40、20 mg/(kg·d)］组大鼠CD8+降低且CD4+/CD8+比值升高(P＜0.05)。结论：紫草素具有提高荷肝癌大鼠免疫功能的作用；其机制可能与紫草素能够有效提高脾淋巴细胞转化率，降低IL-2、TNF-α含量以及提高CD4+百分率、降低CD8+百分率而提高CD4+/CD8+比值有关。
Abstract:
Objective: To explore the influence of Shikonin on immunologic function of the rats suffering liver cancer and its mechanism. Methods: Rat model suffering transplanted tumor of liver cancer were established by hypodermic injection of liver cancer Walker-256 at the armpit, the groups of Shikonin[40, 20 and 10 mg/( kg·d)] and cis-platinum complexes group [2 mg/( kg·d)](n=20) were established by peritoneal injection, and the course was 14 days. Growth conditions of the tumor of the rats were observed, and tumor-inhibitory rate was calculated, histological and morphological structures of the tumor were observed by HE staining; splenic lymphocyte transformation rate was measured by MTT chromometry; the levels of IL-2 and TNF-α were detected by ELISA method; the percentages of CD4+ and CD8+ T lymphocyte subsets by flow cytometry(FCM), and the ratio of CD4+/CD8+ was calculated. Results: Compared with the model group, tumor body shrank and the hardness lowered of the rats after intervened by Shikonin, tumor tissue showed pathological changes including cell shrinking, flake necrosis of the tissue; tumor-inhibitory rate in different intervention groups of Shikonin lifted(P＜0.05); splenic lymphocyte transformation rates in the groups of Shikonin [40, 20 and 10mg/( kg·d)] raised (P＜0.05); the contents of IL-2 and TNF-α decreased (P＜0.05), the percentage of CD4+ in the blood of Shikonin group [40 mg/(kg·d)] evaluated (P＜0.05), CD8+ in Shikonin group[40 and 20 mg/(kg·d)] lowered while the ratio of CD4+/CD8+ raised (P＜0.05). Conclusion: Shikonin could improve immunologic function of the rats suffering liver cancer, and its mechanism might be related to that Shikonin could effectively raise splenic lymphocyte transformation rate, lower the contents of IL-2 and TNF-α, evaluate CD4+ percentage, decrease CD8+ percentage while lift the ratio of CD4+/CD8+.

相似文献/References:

[1]杨宏权,贡布东智△,刘玉玲,等.藏药制剂康速能补胶囊的药效学研究[J].西部中医药,2012,25(08):53.
　YANG Hong-quan,GONG BU Dong-zhi,LIU Yu-ling,et al.Pharmacodynamics of Tibetan Agent KangSu NengBu Capsule[J].Western Journal of Traditional Chinese Medicine,2012,25(09):53.
[2]刘琛,吴黎雅,赵红佳,等.人参养荣汤干预乳腺癌新辅助化疗所致气血两虚证的临床研究[J].西部中医药,2011,24(11):3.
[3]张永科,马天寿.小柴胡汤联合多靶点激素治疗肾病综合征60例[J].西部中医药,2014,27(10):120.
[4]曹军英.纽曼护理对原发性肝癌介入治疗患者焦虑和生活质量的影响[J].西部中医药,2015,28(04):140.
[5]邹勇,殷子斐,程彬彬,等.世界三大饮品预防肝癌研究进展[J].西部中医药,2018,31(05):131.
　ZOU Yong,YIN Zifei,CHENG Binbin,et al.Research Progress of Three Drinks in the Prevention of Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(09):131.
[6]沈玉鹏,任耀全,李冬梅,等.穴位贴敷联合中药辨证治疗对反复呼吸道感染患儿免疫及微量元素的影响[J].西部中医药,2016,29(05):96.
　SHEN Yupeng,REN Yaoquan,LI Dongmei,et al.The Influence of Acupoint Application Combined with Syndrome Differentiation and Herbs on the Immunity and Trace Elements of the Children with Recurrent Respiratory Tract Infection[J].Western Journal of Traditional Chinese Medicine,2016,29(09):96.
[7]杨军民,何耀辉,马宝梅.大黄?虫丸联合化疗治疗原发性肝癌35例[J].西部中医药,2018,31(10):83.
　YANG Junmin,HE Yaohui,MA Baomei.DaHuang ZheChong Pills Combined with Chemotherapy in Treating 35 Cases of Primary Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(09):83.
[8]刘玉华,王敏△.微波消融治疗肝癌的围手术期护理[J].西部中医药,2017,30(04):122.
　LIU Yuhua,WANG Min.Perioperative Care for the Patients with Liver Cancer Treated by Microwave Ablation[J].Western Journal of Traditional Chinese Medicine,2017,30(09):122.
[9]吾斯曼·艾海提,玉苏甫·吐尔逊,吾甫尔·依马尔△.维药孜亚比提片对2型糖尿病大鼠免疫功能的影响[J].西部中医药,2017,30(11):85.
　Osman·Ahait,Yusup·Tursun,Wufuer·Yimaer.Effects of the Uygur Medicine Ziyabiti Tablets on the Immunologic Function of the Rats with Type Two Diabetes Mellitus[J].Western Journal of Traditional Chinese Medicine,2017,30(09):85.
[10]陈艳,童金龙,郑勤.团体认知行为疗法对青年肝癌患者心理状况与生活质量的影响[J].西部中医药,2017,30(11):115.
　CHEN Yan,TONG Jinlong,ZHENG Qin.Effects of Group Cognitive-behavioral Therapy on Psychological Status and Quality of Life of Young Patients with Hepatic Carcinoma[J].Western Journal of Traditional Chinese Medicine,2017,30(09):115.

备注/Memo

备注/Memo:
收稿日期：2018-02-08 *基金项目：邯郸市科学技术研究与发展计划项目(编号1623208076ZC)。 作者简介：赵阳(1984—)，男，主治医师。研究方向：免疫学。
更新日期/Last Update: 2018-09-15